| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $64.6M | +240.9% |
| SG&A Expense | $19.0M | +23.6% |
| Operating Income | -$83.5M | — |
| Income Tax | $0 | -100.0% |
| Net Income | -$71.6M | -4910.8% |
| EPS (Basic) | -$2.01 | -3450.0% |
| EPS (Diluted) | -$2.01 | -3450.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $100.1M | +13.5% |
| Short-term Investments | $153.0M | — |
| Current Assets | $266.2M | +196.9% |
| Total Assets | $271.9M | +195.6% |
| Current Liabilities | $25.9M | +1315.0% |
| Total Liabilities | $26.0M | +1318.6% |
| Stockholders' Equity | $245.9M | +172.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$61.3M | -72.3% |
| Investing Cash Flow | -$148.4M | -294.0% |
| Financing Cash Flow | $234.3M | — |